CoChat

Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank

Open access
Tin Tin, Sandar, Reeves, Gillian K., Key, Timothy J. · 2021 · British Journal of Cancer

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background: Some endogenous hormones have been associated with breast cancer risk, but the nature of these relationships is not fully understood. Methods: UK Biobank was used. Hormone concentrations were measured in serum collected in 2006–2010, and in a repeat subsample ( N ~ 5000) in 2012–13. Incident cancers were identified through data linkage. Cox regression models were used, and hazard ratios (HRs) corrected for regression dilution bias. Results: Among 30,565 pre-menopausal and 133,294 post-menopausal women, 527 and 2,997, respectively, were diagnosed with invasive breast cancer during a median follow-up of 7.1 years. Cancer risk was positively associated with testosterone in post-menopausal women (HR per 0.5 nmol/L increment: 1.18; 95% CI: 1.14, 1.23) but not in pre-menopausal women ( p heterogeneity = 0.03), and with IGF-1 (insulin-like growth factor-1) (HR per 5 nmol/L increment: 1.18; 1.02, 1.35 (pre-menopausal) and 1.07; 1.01, 1.12 (post-menopausal); p heterogeneity = 0.2), and inversely associated with SHBG (sex hormone-binding globulin) (HR per 30 nmol/L increment: 0.96; 0.79, 1.15 (pre-menopausal) and 0.89; 0.84, 0.94 (post-menopausal); p heterogeneity = 0.4). Oestradiol, assessed only in pre-menopausal women, was not associated with risk, but there were study limitations for this hormone. Conclusions: This study confirms associations of testosterone, IGF-1 and SHBG with breast cancer risk, with heterogeneity by menopausal status for testosterone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-021-01392-z

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Associations of hormones and SHBG with the risk of invasive breast cancer by age at blood collection in pre-menopausal women. Hazard ratios stratified for age group, region and deprivation; adjusted for age (underlying time variable), ethnicity, educational level, smoking, alcohol, physical activity, BMI, regular menstrual cycle, parity, age at first birth, time since OCP use, presence of endocrine disorders, family history of breast cancer and other hormones and SHBG; and corrected for regression dilution using repeat measures except for total and calculated free oestradiol.
Fig. 1 Associations of hormones and SHBG with the risk of invasive breast cancer by age at blood collection in pre-menopausal women. Hazard ratios stratified for age group, region and deprivation; adjusted for age (underlying time variable), ethnicity, educational level, smoking, alcohol, physical activity, BMI, regular menstrual cycle, parity, age at first birth, time since OCP use, presence of endocrine disorders, family history of breast cancer and other hormones and SHBG; and corrected for regression dilution using repeat measures except for total and calculated free oestradiol.CC BY · PubMed Central
Fig. 2 Associations of hormones and SHBG with the risk of invasive breast cancer by age at breast cancer diagnosis in pre-menopausal women. Hazard ratios stratified for age group, region and deprivation; adjusted for age (underlying time variable), ethnicity, educational level, smoking, alcohol, physical activity, BMI, regular menstrual cycle, parity, age at first birth, time since OCP use, presence of endocrine disorders, family history of breast cancer and other hormones and SHBG; and corrected for regression dilution using repeat measures except for total and calculated free oestradiol.
Fig. 2 Associations of hormones and SHBG with the risk of invasive breast cancer by age at breast cancer diagnosis in pre-menopausal women. Hazard ratios stratified for age group, region and deprivation; adjusted for age (underlying time variable), ethnicity, educational level, smoking, alcohol, physical activity, BMI, regular menstrual cycle, parity, age at first birth, time since OCP use, presence of endocrine disorders, family history of breast cancer and other hormones and SHBG; and corrected for regression dilution using repeat measures except for total and calculated free oestradiol.CC BY · PubMed Central
Fig. 3 Associations of total and calculated free oestradiol with the risk of invasive breast cancer by phase of the menstrual cycle in pre-menopausal women. Hazard ratios stratified for age group, region and deprivation; and adjusted for age (underlying time variable), ethnicity, educational level, smoking, alcohol, physical activity, BMI, regular menstrual cycle, parity, age at first birth, time since OCP use, presence of endocrine disorders, family history of breast cancer and other hormones and SHBG.
Fig. 3 Associations of total and calculated free oestradiol with the risk of invasive breast cancer by phase of the menstrual cycle in pre-menopausal women. Hazard ratios stratified for age group, region and deprivation; and adjusted for age (underlying time variable), ethnicity, educational level, smoking, alcohol, physical activity, BMI, regular menstrual cycle, parity, age at first birth, time since OCP use, presence of endocrine disorders, family history of breast cancer and other hormones and SHBG.CC BY · PubMed Central
Fig. 4 Geometric mean concentrations of total oestradiol by phase of the menstrual cycle in pre-menopausal women. Menstrual cycle phases were defined by forward dating as early follicular = days 0–5, late follicular = days 6–10, mid-cycle = days 11–14, early luteal = days 15–18, mid-luteal = days 19–24 and late luteal = days ≥25.
Fig. 4 Geometric mean concentrations of total oestradiol by phase of the menstrual cycle in pre-menopausal women. Menstrual cycle phases were defined by forward dating as early follicular = days 0–5, late follicular = days 6–10, mid-cycle = days 11–14, early luteal = days 15–18, mid-luteal = days 19–24 and late luteal = days ≥25.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 75

Metadata

Authors
Tin Tin, S., Reeves, G. K., & Key, T. J.
Affiliations
University of Oxford (GB)
Venue
British Journal of Cancer
Published
2021-04-16
Volume
125
Issue
1
Pages
126-134
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W3155385278
Cited by
71
References
38
Citations by year
2026: 11 · 2025: 16 · 2024: 19 · 2023: 11 · 2022: 12 · 2021: 2
FWCI
4.01
Type
journal article
Language
en
Open access
Licence
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ResearchSpace (University of Auckland) (submittedVersion, cc-by)
Funders
  • Manatu Hauora | Health Research Council of New Zealand (19/031)
  • Cancer Research UK (C570/A16491)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
invasive breast cancer, endogenous hormones, testosterone, insulin-like growth factor I, sex hormone-binding globulin, estradiol, menopausal status, premenopausal women, postmenopausal women, breast cancer risk
MeSH terms
Adult, Aged, Breast Neoplasms, Female, United Kingdom, Humans, Insulin-Like Growth Factor I, Middle Aged, Regression Analysis, Sex Hormone-Binding Globulin, Testosterone, Premenopause, Postmenopause, Biological Specimen Banks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. https://app.cochat.ai/papers/10.1038/s41416-021-01392-z
The paper
Tin Tin, S., Reeves, G. K., & Key, T. J. (2021). Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. British Journal of Cancer. https://doi.org/10.1038/s41416-021-01392-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.